Literature DB >> 9200288

Evaluation of the role of neutrophils in the pathogenesis of acetic acid-induced colitis in mice.

A Higa1, T Eto, Y Nawa.   

Abstract

BACKGROUND: Neutrophils are thought to play a role in the pathogenesis of inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn's disease, since prominent neutrophil infiltration has been observed in the inflamed colonic mucosa of patients with IBD. However, the role of neutrophils in the pathogenesis of IBD and experimental colitis remains equivocal. The aim of the present study is to clarify the possible role of neutrophils in the progression of acetic acid-induced colitis in mice.
METHODS: Using neutropenic mice treated with cyclophosphamide or with an LTB4 receptor antagonist, ONO-4057, the relationship between the severity of macroscopic colonic damage, the extent of myeloperoxidase (MPO) activities in the colonic tissues, and the number of neutrophils in the blood were examined after induction of colitis in mice.
RESULTS: Changes of MPO activity in the colonic tissues paralleled well with the severity of the mucosal damage. In spite of a significant reduction in the number of neutrophils in the blood in cyclophosphamide-treated mice, neither the severity of mucosal damage in the colon nor the increase in MPO activities in the colonic tissues was affected 24 h after induction of colitis. Treatment with ONO-4057 significantly suppressed both the severity of mucosal damage in the colon and MPO activities in the colonic tissues in acetic acid-induced colitis in mice.
CONCLUSIONS: The present results, obtained using treatment with cyclophosphamide and ONO-4057, show that the severity or the progression of acetic acid-induced colitis in mice was not influenced by a reduction of circulating neutrophils to about 25% of base line.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9200288     DOI: 10.3109/00365529709025100

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  6 in total

1.  A new chronic ulcerative colitis model produced by combined methods in rats.

Authors:  Xue-Liang Jiang; Hui-Fei Cui
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

2.  Arsenic trioxide ameliorates murine colon inflammation through inflammatory cell enzymatic modulation.

Authors:  Hichem Moulahoum; Belkacem Mohamed Amine Boumaza; Meriem Ferrat; Abdelkader Bounaama; Bahia Djerdjouri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-11-10       Impact factor: 3.000

3.  Effects of free radicals and leukocytes on increases in blood-brain barrier permeability during colitis.

Authors:  C A Hathaway; W H Percy; J L Williams
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

4.  Vinpocetine Ameliorates Acetic Acid-Induced Colitis by Inhibiting NF-κB Activation in Mice.

Authors:  Bárbara B Colombo; Victor Fattori; Carla F S Guazelli; Tiago H Zaninelli; Thacyana T Carvalho; Camila R Ferraz; Allan J C Bussmann; Kenji W Ruiz-Miyazawa; Marcela M Baracat; Rúbia Casagrande; Waldiceu A Verri
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

5.  Mechanism of reduced colonic contractility in experimental colitis: role of sarcoplasmic reticulum pump isoform-2.

Authors:  Aisha Al-Jarallah; Mabayoje A Oriowo; Islam Khan
Journal:  Mol Cell Biochem       Date:  2006-11-25       Impact factor: 3.842

6.  Modulation of Gut Microbiome Composition and Function in Experimental Colitis Treated with Sulfasalazine.

Authors:  Haihui Zheng; Mingyi Chen; Yuan Li; Yuanyuan Wang; Lin Wei; Ziqiong Liao; Mengxia Wang; Fangli Ma; Qiongfeng Liao; Zhiyong Xie
Journal:  Front Microbiol       Date:  2017-09-07       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.